Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kakolyris

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II studyA Alexopoulos, C Kouroussis, N Malamos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II studyD Mavroudis, A Alexopoulos, N Ziras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trialJ Souglakos, D Mavroudis, S Kakolyris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)D Mavroudis, A Matikas, N Malamos, et al.
Neuropeptides|July 16, 2010
Distinct distribution of corticotropin releasing factor receptors in human breast cancerA Kaprara, K Pazaitou-Panayiotou, M C Chemonidou, et al.
Seminars in Oncology|August 1, 1997
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimenV Georgoulias, C Kourousis, S Kakolyris, et al.
The Journal of Pathology|November 5, 1999
Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC)S Kakolyris, A Giatromanolaki, M Koukourakis, et al.
Seminars in Oncology|August 1, 1997
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancerV Georgoulias, C Kourousis, N Androulakis, et al.
Oncology|October 19, 2006
Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II studyS Kakolyris, K Kalbakis, A Potamianou, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2006
Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinomaS Kakolyris, A Agelidou, N Androulakis, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2001
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II studyA Alexopoulos, C Kouroussis, N Malamos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II studyD Mavroudis, A Alexopoulos, N Ziras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2002
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trialJ Souglakos, D Mavroudis, S Kakolyris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2016
Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)D Mavroudis, A Matikas, N Malamos, et al.
Neuropeptides|July 16, 2010
Distinct distribution of corticotropin releasing factor receptors in human breast cancerA Kaprara, K Pazaitou-Panayiotou, M C Chemonidou, et al.
Seminars in Oncology|August 1, 1997
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimenV Georgoulias, C Kourousis, S Kakolyris, et al.
The Journal of Pathology|November 5, 1999
Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC)S Kakolyris, A Giatromanolaki, M Koukourakis, et al.
Seminars in Oncology|August 1, 1997
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancerV Georgoulias, C Kourousis, N Androulakis, et al.
Oncology|October 19, 2006
Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II studyS Kakolyris, K Kalbakis, A Potamianou, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2006
Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinomaS Kakolyris, A Agelidou, N Androulakis, et al.
Pageof 13